Sign up to save your podcasts
Or
Share Episode 52: The Ethic of New Drug Approvals
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 52: The Ethic of New Drug Approvals
The process of drug approval is long and expensive. To complicate matters, pharmaceutical companies, patients, an the FDA are all invested in the process, for different reasons - and they aren't always the same.
Today we discuss the story of how a new drug came to market and the unusual circumstances around its approval.
Resources:
FDA grants accelerated approval to first drug for Duchenne muscular dystrophy
CDC on Duchenne Muscular Dystrophy
Right to Try
Compassionate Use
Be sure and subscribe in iTunes or Stitcher if you haven’t already. And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!
Listen on iTunes
Listen on Stitcher
Now Available on Google Play Music!
View all episodes
By Kendall Britt, MD and Amy Rogers, MDThe process of drug approval is long and expensive. To complicate matters, pharmaceutical companies, patients, an the FDA are all invested in the process, for different reasons - and they aren't always the same.
Today we discuss the story of how a new drug came to market and the unusual circumstances around its approval.
Resources:
FDA grants accelerated approval to first drug for Duchenne muscular dystrophy
CDC on Duchenne Muscular Dystrophy
Right to Try
Compassionate Use
Be sure and subscribe in iTunes or Stitcher if you haven’t already. And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!
Listen on iTunes
Listen on Stitcher
Now Available on Google Play Music!